Cargando…
Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice
Mutations in CCM1 (aka KRIT1), CCM2, or CCM3 (aka PDCD10) gene cause cerebral cavernous malformation in humans. Mouse models of CCM disease have been established by deleting Ccm genes in postnatal animals. These mouse models provide invaluable tools to investigate molecular mechanism and therapeutic...
Autores principales: | Choi, Jaesung P., Foley, Matthew, Zhou, Zinan, Wong, Weng-Yew, Gokoolparsadh, Naveena, Arthur, J. Simon C., Li, Dean Y., Zheng, Xiangjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981389/ https://www.ncbi.nlm.nih.gov/pubmed/27513872 http://dx.doi.org/10.1371/journal.pone.0160833 |
Ejemplares similares
-
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signaling
por: Zhou, Zinan, et al.
Publicado: (2016) -
Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations
por: Choi, Jaesung P., et al.
Publicado: (2018) -
CCM3 and cerebral cavernous malformation disease
por: Wang, Kang, et al.
Publicado: (2019) -
Structure and vascular function of MEKK3–cerebral cavernous malformations 2 complex
por: Fisher, Oriana S., et al.
Publicado: (2015) -
Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation
por: Yang, Xi, et al.
Publicado: (2023)